首页 | 本学科首页   官方微博 | 高级检索  
检索        

COPD死亡病例医院获得性支气管-肺感染
引用本文:曹国强,杨肇亨,梁先万,张文俊.COPD死亡病例医院获得性支气管-肺感染[J].中华医院感染学杂志,1998(4).
作者姓名:曹国强  杨肇亨  梁先万  张文俊
作者单位:第三军医大学附属大坪医院
摘    要:目的为了解COPD死亡病例医院获得性支气管-肺感染的状况。方法采用痰半定量培养技术结合胸水、血培养及经皮肺穿刺物培养对57例COPD死亡病例进行了前瞻性研究。结果本组病例医院获得性支气管-肺感染的发病率为43.86%,发病前全部使用1种或两种以上抗生素,最高者达8种;70%患者使用过糖皮质激素。致病菌主要为G-杆菌(95.5%),其中以不动杆菌为多见,复合感染及真菌感染较多。部分病例普通痰培养结果并不能确定致病菌。结论不动杆菌已在COPD医院获得性支气管-肺感染中占有很重要地位。确定致病菌应结合X线等辅助检查和临床状况综合。

关 键 词:支气管-肺部感染  医院感染  慢性阻塞性肺病

Study of nosocomial bronchopulmonary infection with COPD clinical death
Cao Guoqiang Yang Zhaoheng Liang Xianwan Zhang Wenjun,Da Ping Hospital Third Military Medical College Chongqing.Study of nosocomial bronchopulmonary infection with COPD clinical death[J].Chinese Journal of Nosocomiology,1998(4).
Authors:Cao Guoqiang Yang Zhaoheng Liang Xianwan Zhang Wenjun  Da Ping Hospital Third Military Medical College Chongqing
Institution:Cao Guoqiang Yang Zhaoheng Liang Xianwan Zhang Wenjun Da Ping Hospital Third Military Medical College Chongqing 400042
Abstract:OBJECTIVE In order to know the state of nosocomial bronchopulmonary infection of COPD clinical deaths was studiea. METHODS Semi-quantitative sputum culture, blood culture, culture of pleural fluid were used in a prospective study of 57 COPD clinical deaths. RESULTS The morbidity was 43.86%. At least one kind of antibiotics were used in all cases. 40 cases (70%) had a history of corticosteroid therapy. The predominant pathogens were Gram-negative bacilli (95.5%), the most were Acinetobacter. Common sputum culture was not reliable in some cases. CONCLUSION It is suggested that patients who had a long period therapy of corticosteroid, inappropriate antibiotic therapy, or depressed immunity function were increased risk of nosocomial bronchopulmonary infections. The diagnosis should be made according to bacteriologic examination combined with the clinical and X-ray manifestations.
Keywords:Bronchopulmonary infection  Nosocomial infection  COPD
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号